Outcomes of total hip arthroplasty in males undergoing testosterone replacement therapy: A propensity-matched analysis
Journal of Clinical Orthopaedics and Trauma · 2026-08 · 79 · 103505
DOI: 10.1016/j.jcot.2026.103505 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Orthopaedics and Trauma, 2026-08. Verfasst von Carlo M Mannina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bioengineering Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Testosterone replacement therapy (TRT) use has risen among older men, including those undergoing total hip arthroplasty (THA). While TRT may influence general musculoskeletal health and surgical outcomes, its relationship with postoperative outcomes following THA remains unclear. This study aimed to evaluate the potential association between preoperative TRT use and postoperative medical and surgical outcomes in male patients undergoing primary THA using a propensity-matched analysis.
Methods
The TriNetX database was queried for male patients undergoing primary THA. Patients with TRT prescribed prior to THA were propensity-score matched 1:1 to non-users by age, body mass index, race, ethnicity, and various medical comorbidities. Outcomes included 90-day rates of readmission, surgical site infection, deep vein thrombosis, pulmonary embolism, and acute renal failure, as well as one- and two-year rates of periprosthetic joint infection (PJI), all-cause reoperation, mechanical complications, and revision THA. After propensity-matching, 1,344 TRT users and 1,344 non-users were identified.
Results
Patients who received preoperative TRT had significantly higher rates of revision THA (4.2 versus 2.1%, P = 0.002), PJI (3.8 versus 2.2%, P = 0.018), all-cause reoperation (5.40 versus 2.92%, P = 0.001), and mechanical complication (6.20 versus 3.79%, P = 0.004) at two-year follow-up. Similar trends were seen in the one-year postoperative period. There was no difference between cohorts in the 90-day rates of readmission or all assessed medical complications.
Conclusion
Preoperative TRT use in male patients prior to THA was associated with significantly increased incidence of revision THA, PJI, reoperation, and mechanical complications at one- and two-year follow-up. This study provides evidence-based information for preoperative counseling of male patients using or considering the use of testosterone supplementation prior to THA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bioengineering Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Zitieren
APA
Mannina, C. M., Ilyas, M. H., Freeman, I. A., Kang, H., Sampson, W. T., & Kwon, Y. M. (2026). Outcomes of total hip arthroplasty in males undergoing testosterone replacement therapy: A propensity-matched analysis. Journal of Clinical Orthopaedics and Trauma, 79, 103505. https://doi.org/10.1016/j.jcot.2026.103505
Vancouver
Mannina CM, Ilyas MH, Freeman IA, Kang H, Sampson WT, Kwon YM. Outcomes of total hip arthroplasty in males undergoing testosterone replacement therapy: A propensity-matched analysis. Journal of Clinical Orthopaedics and Trauma. 2026;79:103505. doi:10.1016/j.jcot.2026.103505
BibTeX
@article{Mannina2026,
author = {Mannina, Carlo M and Ilyas, Muhammad Hamza and Freeman, Isaiah A and Kang, Hahn and Sampson, William T and Kwon, Young-Min},
title = {Outcomes of total hip arthroplasty in males undergoing testosterone replacement therapy: A propensity-matched analysis},
journal = {Journal of Clinical Orthopaedics and Trauma},
year = {2026},
volume = {79},
pages = {103505},
doi = {10.1016/j.jcot.2026.103505}
}
EUVIMED